These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 39039793)

  • 1. The dual loss and gain of function of the FPN1 iron exporter results in the ferroportin disease phenotype.
    Uguen K; Le Tertre M; Tchernitchko D; Elbahnsi A; Maestri S; Gourlaouen I; Férec C; Ka C; Callebaut I; Le Gac G
    HGG Adv; 2024 Oct; 5(4):100335. PubMed ID: 39039793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel SLC40A1 p.Y333H mutation with gain of function of ferroportin: A recurrent cause of haemochromatosis in China.
    Zhang W; Xu A; Li Y; Zhao S; Zhou D; Wu L; Zhang B; Zhao X; Wang Y; Wang X; Duan W; Wang Q; Nan Y; You H; Jia J; Ou X; Huang J;
    Liver Int; 2019 Jun; 39(6):1120-1127. PubMed ID: 30500107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor.
    Praschberger R; Schranz M; Griffiths WJ; Baumgartner N; Hermann M; Lomas DJ; Pietrangelo A; Cox TM; Vogel W; Zoller H
    Biochim Biophys Acta; 2014 Sep; 1842(9):1406-12. PubMed ID: 24859227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering the molecular basis of ferroportin resistance to hepcidin: Structure/function analysis of rare SLC40A1 missense mutations found in suspected hemochromatosis type 4 patients.
    Le Tertre M; Ka C; Guellec J; Gourlaouen I; Férec C; Callebaut I; Le Gac G
    Transfus Clin Biol; 2017 Nov; 24(4):462-467. PubMed ID: 28826751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The
    Ka C; Guellec J; Pepermans X; Kannengiesser C; Ged C; Wuyts W; Cassiman D; de Ledinghen V; Varet B; de Kerguenec C; Oudin C; Gourlaouen I; Lefebvre T; Férec C; Callebaut I; Le Gac G
    Haematologica; 2018 Nov; 103(11):1796-1805. PubMed ID: 30002125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function analysis of the human ferroportin iron exporter (SLC40A1): effect of hemochromatosis type 4 disease mutations and identification of critical residues.
    Le Gac G; Ka C; Joubrel R; Gourlaouen I; Lehn P; Mornon JP; Férec C; Callebaut I
    Hum Mutat; 2013 Oct; 34(10):1371-80. PubMed ID: 23784628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of three novel pathogenic SLC40A1 mutations and genotype/phenotype correlations in 7 Italian families with type 4 hereditary hemochromatosis.
    Majore S; Bonaccorsi di Patti MC; Valiante M; Polticelli F; Cortese A; Di Bartolomeo S; De Bernardo C; De Muro M; Faienza F; Radio FC; Grammatico P; Musci G
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):464-470. PubMed ID: 29154924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular model of the ferroportin intracellular gate and implications for the human iron transport cycle and hemochromatosis type 4A.
    Guellec J; Elbahnsi A; Tertre ML; Uguen K; Gourlaouen I; Férec C; Ka C; Callebaut I; Gac GL
    FASEB J; 2019 Dec; 33(12):14625-14635. PubMed ID: 31690120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin disease.
    Viveiros A; Panzer M; Baumgartner N; Schaefer B; Finkenstedt A; Henninger B; Theurl I; Nachbaur K; Weiss G; Haubner R; Decristoforo C; Tilg H; Zoller H
    Liver Int; 2020 Aug; 40(8):1941-1951. PubMed ID: 32450003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive functional annotation of 18 missense mutations found in suspected hemochromatosis type 4 patients.
    Callebaut I; Joubrel R; Pissard S; Kannengiesser C; Gérolami V; Ged C; Cadet E; Cartault F; Ka C; Gourlaouen I; Gourhant L; Oudin C; Goossens M; Grandchamp B; De Verneuil H; Rochette J; Férec C; Le Gac G
    Hum Mol Genet; 2014 Sep; 23(17):4479-90. PubMed ID: 24714983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term phlebotomy successfully alleviated hepatic iron accumulation in a ferroportin disease patient with a mutation in SLC40A1: a case report.
    Nishina S; Tomiyama Y; Ikuta K; Tatsumi Y; Toki Y; Kato A; Kato K; Yoshioka N; Sasaki K; Hara Y; Hino K
    BMC Gastroenterol; 2021 Mar; 21(1):111. PubMed ID: 33673803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis.
    Nemeth E; Ganz T
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepcidin and iron regulatory proteins coordinately regulate ferroportin 1 expression in the brain of mice.
    Wang L; Liu X; You LH; Ci YZ; Chang S; Yu P; Gao G; Chang YZ
    J Cell Physiol; 2019 May; 234(5):7600-7607. PubMed ID: 30370612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepcidin and ferroportin: the new players in iron metabolism.
    De Domenico I; Ward DM; Kaplan J
    Semin Liver Dis; 2011 Aug; 31(3):272-9. PubMed ID: 21901657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation.
    Griffiths WJ; Mayr R; McFarlane I; Hermann M; Halsall DJ; Zoller H; Cox TM
    Hepatology; 2010 Mar; 51(3):788-95. PubMed ID: 19937651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel missense mutation in SLC40A1 results in resistance to hepcidin and confirms the existence of two ferroportin-associated iron overload diseases.
    Létocart E; Le Gac G; Majore S; Ka C; Radio FC; Gourlaouen I; De Bernardo C; Férec C; Grammatico P
    Br J Haematol; 2009 Nov; 147(3):379-85. PubMed ID: 19709084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular basis of hepcidin-resistant hereditary hemochromatosis.
    Fernandes A; Preza GC; Phung Y; De Domenico I; Kaplan J; Ganz T; Nemeth E
    Blood; 2009 Jul; 114(2):437-43. PubMed ID: 19383972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic expression of hemochromatosis genes in two mouse strains after phlebotomy and iron overload.
    Bondi A; Valentino P; Daraio F; Porporato P; Gramaglia E; Carturan S; Gottardi E; Camaschella C; Roetto A
    Haematologica; 2005 Sep; 90(9):1161-7. PubMed ID: 16154838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron Export through the Transporter Ferroportin 1 Is Modulated by the Iron Chaperone PCBP2.
    Yanatori I; Richardson DR; Imada K; Kishi F
    J Biol Chem; 2016 Aug; 291(33):17303-18. PubMed ID: 27302059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and clinical heterogeneity of ferroportin disease.
    Cremonesi L; Forni GL; Soriani N; Lamagna M; Fermo I; Daraio F; Galli A; Pietra D; Malcovati L; Ferrari M; Camaschella C; Cazzola M
    Br J Haematol; 2005 Dec; 131(5):663-70. PubMed ID: 16351644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.